Choi, Y., Ma, Y., Tom, S., Danilkovitch, A., & Yu, L. (2025). An engineered adipose formulation decreases hepatic inflammation and fibrosis in a rodent model of metabolic dysfunction-associated steatotic liver disease. Frontiers Media S.A.
Chicago Style (17th ed.) CitationChoi, Youngshim, Yinyan Ma, Samson Tom, Alla Danilkovitch, and Liqing Yu. An Engineered Adipose Formulation Decreases Hepatic Inflammation and Fibrosis in a Rodent Model of Metabolic Dysfunction-associated Steatotic Liver Disease. Frontiers Media S.A, 2025.
MLA (9th ed.) CitationChoi, Youngshim, et al. An Engineered Adipose Formulation Decreases Hepatic Inflammation and Fibrosis in a Rodent Model of Metabolic Dysfunction-associated Steatotic Liver Disease. Frontiers Media S.A, 2025.
Warning: These citations may not always be 100% accurate.